
Joel Nee-Lartley Blankson MD
Professor of Medicine, Johns Hopkins University School of Medicine
Join to view full profile
1800 Orleans StreetBaltimore, MD 21287
Phone+1 410-955-5000
Fax+1 410-955-5001
Dr. Blankson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 1998 - 2002
Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
Weill Cornell MedicineClass of 1995
Certifications & Licensure
MD State Medical License 1998 - 2026
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2012
Publications & Presentations
PubMed
- Antigen Stimulation Reactivates HIV-1 Proviruses Despite Integration in Repressive Chromatin.Angelica Camilo-Contreras, Filippo Dragoni, Hao Zhang, Junlin Zhuo, Daniel Smith
Biorxiv. 2026-06-23 - 5' leader defects drive persistent HIV-1 viremia on long-term ART.Julia R Box, Angelica Camilo-Contreras, Filippo Dragoni, Feng Yun Yue, Vitaliy Matveev
Nature Communications. 2026-06-08 - 1 citationsRecapitulating the qualities of HIV-specific CD8 + T cells from spontaneous controllers.Karla DeLucas, Joel N Blankson, Rachel L Rutishauser
Current Opinion in HIV and AIDS. 2026-05-01
Journal Articles
- Interferon-Α Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8+ T CellsJoel Blankson, MD, mBio
- CMPK2 and BCL-G Are Associated with Type 1 Interferon–Induced HIV Restriction in HumansJustin R. Bailey, Joel N. Blankson, Robert F. Siliciano, Stuart C. Ray, Ramy El-Diwany, Science Magazine
- Highly Attenuated Infection with a Vpr-Deleted Molecular Clone of HIV-1Peter A Anton, Jennifer A Fulcher, Otto O Yang, Joel N Blankson, The Journal of Infectious Diseases
Press Mentions
Researchers See Dramatic Drop in HIV-Infected Immune Cells in Patient After Cancer Treatment ReceivedDecember 15th, 2025
Breakthrough COVID Infections More Likely in People Living with HIVJune 9th, 2022
Antibodies from Covid Vaccines May Be Weaker Against Omicron, Study FindsApril 27th, 2022
Grant Support
- Identification and elimination of antigen-specific expanded clonesJOHNS HOPKINS UNIVERSITY2026–2028
- Eradication of clonally expanded CD4+ T cellsJOHNS HOPKINS UNIVERSITY2022–2025
- CD8+ T Cell Mediated Inhibition Of HIV-1 Replication In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2009–2012
- Analysis Of HIV-1 In Mucosal Tissue In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2011
- Characterization Of HIV Excape Mutants And T Cell Responses In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2007
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/joel-blankson
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









